30% of Your Patients are Automatically Not a Target - Return On Focus Return On Focus | https://returnonfocus.com | Return On Focus

What We Think

EVIDENCE bLOG

30% of Your Patients are Automatically Not a Target

Too many of the DTC ROI models that I review, start with 100% of the population with the disease prevalence being the potential target. It ignores the evidence that’s been established across a number of disease states.

The fact is, roughly 30% of patients do not want to play a role in their treatment.

I’ll use evidence from research with metastatic breast cancer patients because surely this is the disease state with patients most apt to have a collaborative treatment approach with their physician. Grunfeld, in 2006, demonstrated that even as patients fail lines of chemotherapy in metastatic breast cancer a significant minority remain passive in their treatment even as their condition progresses.

30% of Patients Not Your Target

In developing a realistic ROI model for patient marketing investments in metastatic breast cancer, I would automatically discount the targeted population by at least 30% based on the evidence provided by Grunfeld. It’s difficult to make the case that marketing efforts would change a patient’s innate behavior when blowing through a line of chemotherapy does not.

Yet another illustration of how you can leverage our Evidence-Based Marketing approach to easily and efficiently to get more mileage out of your marketing and market research efforts.

Follow us on
Pinterest Twitter slideshare
Contact Us
XXX

Powered by WordPress